Business Details
Trusted USFDA-Approved CDMO for Generic Pharmaceuticals
At Aavis Pharmaceuticals, we are committed to advancing healthcare through the development and manufacturing of high-quality generic pharmaceuticals. As a USFDA-approved company based in Atlanta, Georgia, we specialize in contract development and manufacturing services that prioritize innovation, regulatory compliance, and patient-centric solutions. Our expertise spans immediate and controlled-release oral solid dosage forms, bioavailability enhancement, and taste-masking technologies, addressing complex formulation challenges with cutting-edge scientific research. With a dedicated team focused on continuous process improvement and strategic global partnerships, we ensure reliable supply chains and timely access to critical medications.Our mission is to empower healthier lives by delivering affordable, trustworthy treatments while maintaining rigorous quality standards. By integrating advanced technology with deep industry experience, we provide tailored solutions that meet the evolving needs of patients and partners worldwide. Our commitment to excellence is reflected in every stage of our operations, from R&D to commercial manufacturing, ensuring that every product we develop aligns with our core values of integrity and service.
Services
Generic Drug Development
Contract Research Services
Analytical Method Development
Stability Studies
Immediate Release Tablets
Controlled Release Technologies
Bioavailability Enhancement
Taste Masking Solutions
Contract Manufacturing
In-Licensing Partnerships
Highlights and features
- We are a USFDA-approved contract manufacturing organization.
- We specialize in complex oral solid dosage form development.
- Our team has extensive experience in bioavailability enhancement technologies.
- We maintain rigorous quality control and regulatory compliance standards.
- We offer scalable solutions from R&D to commercial manufacturing.
Associations and certifications
- USFDA
Services
Contract Drug Manufacturing
We provide end-to-end contract manufacturing solutions for generic pharmaceuticals, from clinical batches to commercial-scale production. Our USFDA-approved facilities ensure compliance with global quality standards while delivering scalable, cost-effective manufacturing processes tailored to client requirements.
Generic Drug Development
Our expertise includes developing complex generic formulations such as controlled-release oral solids and bioavailability-enhanced products. We offer comprehensive R&D services covering pre-formulation studies, process development, and regulatory filing support to overcome competitive barriers in drug development.
Analytical Method Development
We develop and validate robust analytical methods for drug characterization, ensuring accuracy and compliance with regulatory requirements. Our services include stability testing programs that assess product shelf-life under various environmental conditions to guarantee long-term quality.
Controlled Release Technologies
Our controlled release platforms enable customized drug delivery profiles, including sustained, delayed, and pulsatile release mechanisms. These technologies improve patient compliance by reducing dosing frequency while maintaining therapeutic efficacy through precise, time-dependent drug release patterns.
In-Licensing Partnerships
We actively seek strategic in-licensing opportunities with global partners to expand our product portfolio and distribution network. By identifying innovative drug candidates aligned with our development capabilities, we accelerate market access for high-quality generic medications through collaborative research and commercialization efforts.
Questions
What services does Aavis Pharmaceuticals offer?
We provide contract development and manufacturing services for generic pharmaceuticals, including formulation R&D, analytical method validation, controlled-release technologies, and commercial-scale production.
Is Aavis Pharmaceuticals USFDA approved?
Yes, we are a USFDA-approved contract manufacturing organization specializing in high-quality generic drug development and production.
What types of drug formulations do you develop?
We focus on complex oral solid dosage forms, including immediate release, controlled release, orally disintegrating tablets, and taste-masked formulations for improved patient compliance.
Do you offer global partnership opportunities?
Yes, we actively pursue in-licensing and out-licensing partnerships worldwide to expand access to critical generic medications through collaborative development and distribution networks.
